Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Respiratory Morbidity Among Children Who Were Born by Elective Cesarean Section After 37-38 Weeks vs. 39 Weeks and More

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02060994
Recruitment Status : Completed
First Posted : February 12, 2014
Last Update Posted : May 2, 2014
Sponsor:
Information provided by (Responsible Party):
Erez Nadir, MD, Hillel Yaffe Medical Center

Brief Summary:

Background: It is known that after Cesarean section is correlated with respiratory complication more, if done after 37-38 week of gestation than if done after 39 weeks or more.

Goal: The aim of the current study is to find out if these respiratory complications extend to later life.

Methode: Reviewing the patients' medical file, and collecting data about respiratory complication.


Condition or disease Intervention/treatment
Respiratory Complications Other: No intervention

Detailed Description:

Background: It is known that after Cesarean section is correlated with respiratory complication more, if done after 37-38 week of gestation than if done after 39 weeks or more. We have already conducted a study about this topic, and published our results.

Goal: The aim of the current study is to find out if these respiratory complications extend to later life.

Method: Reviewing the patients' medical file, and collecting data about respiratory complication. We will use the same patients we used at the first study. Respiratory complications are defined as diagnosis of asthma, treatment by inhalations or systemic steroids, or consultation by pulmonologist.


Layout table for study information
Study Type : Observational
Actual Enrollment : 123 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Respiratory Morbidity Among Children Who Were Born by Elective Cesarean Section After 37-38 Weeks vs. 39 Weeks and More
Study Start Date : February 2014
Actual Primary Completion Date : April 2014
Actual Study Completion Date : April 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cesarean Section

Group/Cohort Intervention/treatment
37-38 weeks

Children who were born by elective Cesarean section after 37-38 gestational weeks.

Intervention: No intervention.

Other: No intervention
No intervention

39 week or more
Children who were born by elective Cesarean section after 39 gestational weeks or more Intervention: No intervention.
Other: No intervention
No intervention




Primary Outcome Measures :
  1. There are respiratory complications. [ Time Frame: Age 4-8 years ]
    Respiratory complications are defined as any of: asthma, inhalation therapy, systemic steroids therapy, consultation by a pulmonologist



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children born in 2007-2009 in "Hillel Yaffe" medical center by elective Cesarean section according to a list of IDs we have.
Criteria

Inclusion Criteria:

  • Children born in 2007-2009 our medical center by elective Cesarean section according to a list of IDs we have.

Exclusion Criteria:

  • Children with respiratory congenital defect that was not known at the first week of life.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02060994


Locations
Layout table for location information
Israel
Hillel Yaffe medical center
Hadera, North, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Erez Nadir, MD Hillle Yaffe medical center, Hadera, Israel

Publications:
Layout table for additonal information
Responsible Party: Erez Nadir, MD, Neonatologist, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT02060994     History of Changes
Other Study ID Numbers: HYMC-0088-13-CTIL
First Posted: February 12, 2014    Key Record Dates
Last Update Posted: May 2, 2014
Last Verified: May 2014